Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ABVC BioPharma Inc.

    NASDAQ: ABVC · Real-Time Price · USD
    2.02
    0.07 (3.59%)
    At close: Jun 17, 2025, 3:59 PM
    2.00
    -0.99%
    After-hours: Jun 17, 2025, 06:22 PM EDT

    ABVC BioPharma Statistics

    Share Statistics

    ABVC BioPharma has 16.98M shares outstanding. The number of shares has increased by 7.66% in one year.

    Shares Outstanding

    n/a
    		 16.98M

    Shares Change (YoY)

    n/a
    		 7.66%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.78%

    Shares Floating

    n/a
    		 14.55M

    Failed to Deliver (FTD) Shares

    n/a
    		 11,117

    FTD / Avg. Volume

    n/a
    		 2.91%

    Short Selling Information

    The latest short interest is 450.56K, so 2.65% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 450.56K

    Short % of Shares Out

    n/a
    		 2.65%

    Short % of Float

    n/a
    		 3.17%

    Short Ratio (days to cover)

    n/a
    		 1.7

    Valuation Ratios

    The PE ratio is -1.49 and the forward PE ratio is 1.37. ABVC BioPharma's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.49

    Forward PE

    n/a
    		 1.37

    PS Ratio

    n/a
    		 14.38

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 5.97

    P/FCF Ratio

    n/a
    		 -4.05

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ABVC BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.33, with a Debt / Equity ratio of 1.98.

    Current Ratio

    n/a
    		 0.33

    Quick Ratio

    n/a
    		 0.33

    Debt / Equity

    n/a
    		 1.98

    Debt / EBITDA

    n/a
    		 -0.56

    Debt / FCF

    n/a
    		 -1.34

    Interest Coverage

    n/a
    		 -5.7

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $31,849.25

    Profits Per Employee

    n/a
    		 $-306,437.5

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0.07

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -111K

    Effective Tax Rate

    n/a
    		 2.06%

    Stock Price Statistics

    The stock price has increased by 148.02% in the last 52 weeks. The beta is 0.19, so ABVC BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.19

    52-Week Price Change

    n/a
    		 148.02%

    50-Day Moving Average

    n/a
    		 1.24

    200-Day Moving Average

    n/a
    		 0.77

    Relative Strength Index (RSI)

    n/a
    		 68.55

    Average Volume (20 Days)

    n/a
    		 382,553

    Income Statement

    In the last 12 months, ABVC BioPharma had revenue of 509.59K and earned -4.9M in profits. Earnings per share was -0.43.

    Revenue

    n/a
    		 509.59K

    Gross Profit

    n/a
    		 508.83K

    Operating Income

    n/a
    		 -4.71M

    Net Income

    n/a
    		 -4.9M

    EBITDA

    n/a
    		 -4.34M

    EBIT

    n/a
    		 -4.54M

    Earnings Per Share (EPS)

    n/a
    		 -0.43
    Full Income Statement

    Balance Sheet

    The company has 248.38K in cash and 2.43M in debt, giving a net cash position of -2.18M.

    Cash & Cash Equivalents

    n/a
    		 248.38K

    Total Debt

    n/a
    		 2.43M

    Net Cash

    n/a
    		 -2.18M

    Retained Earnings

    n/a
    		 -68.95M

    Total Assets

    n/a
    		 14.88M

    Working Capital

    n/a
    		 -5.21M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.81M and capital expenditures 0, giving a free cash flow of -1.81M.

    Operating Cash Flow

    n/a
    		 -1.81M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -1.81M

    FCF Per Share

    n/a
    		 -0.15
    Full Cash Flow Statement

    Margins

    Gross margin is 99.85%, with operating and profit margins of -924.73% and -963.57%.

    Gross Margin

    n/a
    		 99.85%

    Operating Margin

    n/a
    		 -924.73%

    Pretax Margin

    n/a
    		 -1055.29%

    Profit Margin

    n/a
    		 -963.57%

    EBITDA Margin

    n/a
    		 -853.49%

    EBIT Margin

    n/a
    		 -923.29%

    FCF Margin

    n/a
    		 -355.02%

    Dividends & Yields

    ABVC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ABVC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 25, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jul 25, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -5.4

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist